Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical immunology"
DOI: 10.1016/j.clim.2018.03.002
Abstract: This study evaluated the short-term effects of tofacitinib treatment on peripheral blood leukocyte phenotype and function, and the reversibility of any such effects following treatment withdrawal in healthy volunteers. Cytomegalovirus (CMV)-seropositive subjects received oral tofacitinib… read more here.
Keywords: tofacitinib treatment; cell counts; blood; withdrawal ... See more keywords
Tofacitinib in the treatment of refractory eczemas – a case series
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2022.2082355
Abstract: Abstract Janus Kinase inhibitors have been shown to be effective in the treatment of various dermatoses such as alopecia areata, psoriasis, vitiligo and atopic dermatitis. The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway… read more here.
Keywords: case series; treatment; tofacitinib treatment;
Tofacitinib for the treatment of primary cutaneous amyloidosis: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15312
Abstract: Dear Editor, Primary cutaneous amyloidosis (PCA) is featured by the deposition of amyloid within the papillary dermis without involving other organs. PCA is common in Asians who suffer plaque on the extensor surfaces of the… read more here.
Keywords: treatment primary; primary cutaneous; cutaneous amyloidosis; tofacitinib treatment ... See more keywords
AB0344 FACTORS WHICH CONTRIBUTE PERSISTENCY AND OPTIMAL USE OF TOFACITINIB; LESSONS FROM LONG TERM DAILY CLINICAL USE OF TOFACITINIB
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.2783
Abstract: Recently, tofacitinib treatment in rheumatoid arthritis (RA) is thought to be not inferior to other biologic disease-modifying antirheumatic drugs (bDMARDS) such as TNF-inhibitor. However, approval of tofacitinib for treatment with RA is relatively recent as… read more here.
Keywords: efficacy; use tofacitinib; disease; tofacitinib treatment ... See more keywords
Comment on the article “Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology”
Sign Up to like & getrecommendations! Published in 2018 at "Reumatologia"
DOI: 10.5114/reum.2018.80726
Abstract: Thank you very much to the authors for the interesting article on the use of tofacitinib in the treatment of rheumatoid arthritis (RA). Extensive team work is in my opinion the best way to present… read more here.
Keywords: tofacitinib treatment; article; treatment; small molecule ... See more keywords